BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Avgerinos K, Tziomalos K. Effects of glucose-lowering agents on ischemic stroke. World J Diabetes 2017; 8(6): 270-277 [PMID: 28694927 DOI: 10.4239/wjd.v8.i6.270]
URL: https://www.wjgnet.com/1948-9358/full/v8/i6/270.htm
Number Citing Articles
1
M. Yu. Maksimova, A. V. Ivanov, K. A. Nikiforova, F. R. Ochtova, E. T. Suanova, E. D. Virus, I. S. Zimina, M. A. Piradov, A. A. Kubatiev. Type 2 diabetes mellitus in patients with acute ischemiс stroke is associated with a decrease in plasma glutathione levelsRussian neurological journal 2020; 25(5): 29 doi: 10.30629/2658-7947-2020-25-5-29-35
2
Vladimer Darsalia, Martin Larsson, Thomas Klein, Cesare Patrone. The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitorsCardiovascular Diabetology 2018; 17(1) doi: 10.1186/s12933-018-0674-3
3
Natalia García-Casares, Guillermo González-González, Carlos de la Cruz-Cosme, Francisco J Garzón-Maldonado, Carmen de Rojas-Leal, María J Ariza, Manuel Narváez, Miguel Ángel Barbancho, Juan Antonio García-Arnés, Francisco J. Tinahones. Effects of GLP-1 receptor agonists on neurological complications of diabetesReviews in Endocrine and Metabolic Disorders 2023; 24(4): 655 doi: 10.1007/s11154-023-09807-3
4
Benjamin A. Howie, Alex M. Witek, M. Shazam Hussain, Mark D. Bain, Gabor Toth. Carotid Endarterectomy and Carotid Artery Stenting in a Predominantly Symptomatic Real-World Patient PopulationWorld Neurosurgery 2019; 127: e722 doi: 10.1016/j.wneu.2019.03.254